Because CD8+ T lymphocytes are also important players in the pathogenesis of MS (1), we assessed the effect of IFN-β and vitamin D treatments on cytokine expression by memory CD8+ T lymphocytes. This evidence concerns the gene IFNB1 and myeloid sarcoma.